US6949637B2ExpiredUtilityPatentIndex 48
Methods for diagnosis, prediction and treatment of asthma and other inflammatory conditions based on eotaxin coding sequence polymorphism
Est. expiryMay 16, 2017(expired)· nominal 20-yr term from priority
C12Q 1/6883C12Q 2600/156
48
PatentIndex Score
1
Cited by
6
References
2
Claims
Abstract
Methods and compositions for diagnosing and treating asthma are provided. The methods involve the discovery of a correlation between an eotaxin gene polymorphism and the ocurrence of asthma.
Claims
exact text as granted — not AI-modified1. A composition comprising an isolated nucleic acid consisting of the wild type normal eotaxin gene sequence as shown in SEQ ID NO: 1, wherein said nucleic acid includes a guanine to adenine substitution 67 base pairs following the ATG initiation codon of the wild type normal eotaxin gene, whereby counting is initiated at the A in that codon.
2. A composition comprising an isolated oligonucleotide consisting of a nucleotide sequence selected from the group consisted of:
AGAAACCACCACCTCTCACG; (SEQ ID NO: 2) GAGAATTTGCAGTGAGTCTGT; (SEQ ID NO: 3) GGGGCTTACCTGGCCCAAC; (SEQ ID NO: 4) GGGGCTTACCTGGCCCAAT; (SEQ ID NO: 5) and TCAAGGAAGGTTCTTAGATCG. (SEQ ID NO. 6).Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.